Oxidative rearrangement processes in the biosynthesis of gilvocarcin V.

  title={Oxidative rearrangement processes in the biosynthesis of gilvocarcin V.},
  author={T. Liu and C. Fischer and Claus Beninga and J. Rohr},
  journal={Journal of the American Chemical Society},
  volume={126 39},
Gilvocarcin V (GV), an antitumor agent produced by Streptomyces griseoflavus Gö 3592 and various other streptomycetes, is the most important representative of the distinct family of benzo[d]naphtho[1,2-b]pyran-6-one aryl C-glycoside antibiotics, which show excellent antitumor activity and a remarkably low toxicity. The most intriguing step of its biosynthesis is an oxidative rearrangement cascade, in which the C-5/C-6 of an angucyclinone precursor bond is broken. Although this oxidative… Expand
Enzymatic total synthesis of defucogilvocarcin M and its implications for gilvocarcin biosynthesis.
A complete, one-pot, enzymatic total synthesis of defucogilvocarcin M(1), a model compound that contains the unique chromophore common to all members of the gil Vocarcin group of natural products is reported. Expand
OF DISSERTATION INVESTIGATING KEY POST-PKS ENZYMES FROM GILVOCARCIN BIOSYNTHETIC PATHWAY Gilvocarcin V (GV) belongs to the angucycline class of antibiotics that possesses remarkable anticancer andExpand
Delineation of gilvocarcin, jadomycin, and landomycin pathways through combinatorial biosynthetic enzymology.
Investigations of the complex biosyntheses of the angucycline group anticancer drugs landomycin, jadomycin and gilvocarcin revealed that in vivo and in silico studies were insufficient to delineate the true biosynthetic sequence of events. Expand
Plasticity in gilvocarcin-type C-glycoside pathways: discovery and antitumoral evaluation of polycarcin V from Streptomyces polyformus.
Cytotoxicity profiling of polycarcin V in a panel of 37 tumor cell lines indicated significant antitumoral activity with a pronounced selectivity for non-small-cell lung cancer, breast cancer and melanoma cells. Expand
Isolation and elucidation of the chrysomycin biosynthetic gene cluster and altering the glycosylation patterns of tetracenomycins and mithramycin-pathway molecules
The purpose of this research was to investigate the biosynthesis of several type II polyketide compounds with the goal of improving the bioactivities of these drugs through combinatorial biosynthesis. Expand
Elucidation of Oxygenation Steps during Oviedomycin Biosynthesis and Generation of Derivatives with Increased Antitumor Activity
Eight different angucyclinones produced in Streptomyces albus by combining three oxygenase genes together with the polyketide synthase and cyclases genes from the oviedomycin biosynthetic gene cluster from StrePTomyces antibioticus ATCC 11891 were fully characterized for the first time. Expand
Angucyclines: Biosynthesis, mode-of-action, new natural products, and synthesis.
The main focus of this article is on new synthetic approaches and biosynthetic investigations, most of which were published between 1997 and 2010, but go beyond, e.g. for some biosyntheses all the way back to the 1980s, to provide the necessary context of information. Expand
A biosynthetic pathway for BE-7585A, a 2-thiosugar-containing angucycline-type natural product.
The results indicated an unusual manner of angular tetracyclic ring construction, perhaps via a Baeyer-Villiger type rearrangement, which set the stage for future biochemical studies of 2-thiosugar biosynthesis and BE-7585A assembly. Expand
Functional and Structural Insights into a Novel Promiscuous Ketoreductase of the Lugdunomycin Biosynthetic Pathway
Mutational analysis uncovered key residues for substrate access, position, and catalysis as well as specific determinants that control its dual functionality, which hold promise for the discovery and engineering of other promiscuous reductases that may be harnessed for the generation of novel biocatalysts for chemoenzymatic applications. Expand
Roles of the synergistic reductive O-methyltransferase GilM and of O-methyltransferase GilMT in the gilvocarcin biosynthetic pathway.
Two enzymes of the gilvocarcin biosynthetic pathway, GilMT and GilM, with unclear functions were investigated by in vitro studies using purified, recombinant enzymes along with synthetically prepared intermediates to identify a pivotal enzyme in the pathway that exhibits dual functionality. Expand